Cardiff Oncology, Inc.CRDFNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank21
Studio
Year-over-Year Change

Return on invested capital

Latest
-105.93%
Near historical average
Percentile
P21
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-100.03%
Historical baseline
PeriodValueYoY Change
2025-105.93%-83.9%
2024-57.59%+8.8%
2023-63.17%-72.7%
2022-36.59%-82.0%
2021-20.10%-36.4%
2020-14.74%+91.9%
2019-181.88%-19.5%
2018-152.16%+42.5%
2017-264.68%-155.9%
2016-103.45%-